The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
South East; Berkshire; Buckinghamshire and Oxfordshire
Location of affected unit(s)
Bracknell
Sector
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
220 jobs Number of planned job losses
Announcement Date
11 October 2007
Employment effect (start)
1 October 2009
Foreseen end date
31 December 2010
Description
Boehringer Ingelheim UK, a firm that operates in the pharmaceutical sector and is a subsidiary of multi-national group Boehringer Ingelheim, is to cut 220 jobs in Bracknell. The firm’s site at Bracknell, at which 340 are employed, produces respiratory products in a specific form called Unit Dose Vials (UDVs). The job cuts are due to the firm’s decision to stop producing UDVs. A spokesman for the firm stated:
‘The reason the decision has been taken to phase out production is that in the future there will be no new products in UDV form coming from the Boehringer Ingelheim pipeline and the focus is now on new device technologies for respiratory products. Additionally, the current UDV products now face low priced competition meaning that it is not possible to compete given the company's production costs in Bracknell.’
The job cuts will not begin to be implemented until October 2009, and the restructuring is scheduled to be completed by 2010. Boehringer Ingelheim employs 1000 in the UK and 38,400 globally.
Sources
11 October 2007: BBC News
Citation
Eurofound (2007), Boehringer Ingelheim UK, Internal restructuring in United Kingdom, factsheet number 65917, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/65917.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
